C$
3.94
May 13
New Key Statistics Module, Z-Score and F-Score
TSX:HLS Key Ratios
Market Cap C$ M | 125.35 |
Enterprise Value C$ M | 215.18 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.96 |
Price/Sales | 1.49 |
Price/Free Cash Flow | 5.95 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 81.00 |
EPS (TTM) C$ | -1.15 |
Beneish M-Score | -3.31 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -10.00 |
y-y EBITDA Growth Rate % | -28.90 |
EV-to-EBIT | -8.39 |
EV-to-EBITDA | 12.35 |
PEG | -- |
Shares Outstanding M | 31.81 |
Net Margin (%) | -43.59 |
Operating Margin % | -16.43 |
Pre-tax Margin (%) | -44.03 |
Quick Ratio | 1.29 |
Current Ratio | 1.65 |
ROA % (ttm) | -12.17 |
ROE % (ttm) | -24.70 |
ROIC % (ttm) | -5.22 |
Dividend Yield % | 1.27 |
Altman Z-Score | -0.57 |
TSX:HLS Number of Guru Trades
TSX:HLS Volume of Guru Trades
Gurus Latest Trades with TSX:HLS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:HLS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HLS Therapeutics Inc Insider Transactions
No Available Data